Advertisement · 728 × 90

Posts by DhRS

The thing with not dichotomizing continuous variable is it depends on context. Lots of stuff are dichotomized for legal/clinical/social reasons: drinking/voting age, tax rates, cancer stages. Ken Rothman had a tweet saying, we use a yes/no for measles diagnosis and not number of rashes/spots

4 days ago 1 0 2 0

breakpoints. So, I only ask for codes and execute them manually, essentially separating generation and execution. I know it slower but keeps me sane. 2

2 weeks ago 0 0 0 0

Thank you so much; these are so helpful. Not sure I am missing something but I didn't see "stay in this directory" in your Claude prompt.
Every time I've tried to do similar (download/scrape/clean data), I get some weird stuff. I think being super-precise is the key but hard to anticipate all 1/

2 weeks ago 0 0 1 0
Post image

Lasagna is superior!

3 weeks ago 1 0 0 0

I happened to look at one of these APE paper in my field. Most of the state-level policy implementation dates were wrong. Dates were pulled from a couple of published sources, but didn't pull them correctly. Fancy stat modeling; don't get basics right

1 month ago 2 0 0 0

My 2 cents: 1) high time conferences switched to digital posters; waste is enormous with physical posters; and 2) digital posters can allow for an overview and detailed info on methods/results if a reader chooses so. Overview can be of ~100 words with a sentence or two for each section

2 months ago 0 0 1 0

What's the issue with this?

2 months ago 0 0 1 0

Why not just use random effects?

2 months ago 0 0 1 0
Advertisement
Except for vaccination for adults aged ≥65 years, ACIP makes no preferential recommendation for a specific vaccine when more than one licensed and recommended vaccine is available. Among adults aged ≥65 years any one of the following higher dose or adjuvanted influenza vaccines is preferentially recommended: HD-IIV3, RIV3, or aIIV3. If none of these three vaccines is available at an opportunity for vaccine administration, any other available age-appropriate influenza vaccine should be used (4,5).

Except for vaccination for adults aged ≥65 years, ACIP makes no preferential recommendation for a specific vaccine when more than one licensed and recommended vaccine is available. Among adults aged ≥65 years any one of the following higher dose or adjuvanted influenza vaccines is preferentially recommended: HD-IIV3, RIV3, or aIIV3. If none of these three vaccines is available at an opportunity for vaccine administration, any other available age-appropriate influenza vaccine should be used (4,5).

Not defending FDA's decision, but this is in the same ACIP MMWR summary and what the decision is based on

2 months ago 0 0 1 0

"Core competencies are whatever our [Authors] areas of research are"

2 months ago 0 0 0 0

What is your complaint about this piece?

3 months ago 0 0 0 0

She is his frequent collaborator/co-author; they probably have like 50 papers together

4 months ago 0 0 0 0
Problems with evidence assessment in COVID-19 health policy impact evaluation: a systematic review of study design and evidence strength Introduction Assessing the impact of COVID-19 policy is critical for informing future policies. However, there are concerns about the overall strength of COVID-19 impact evaluation studies given the c...

This review has some nice ones about COVID policies:
bmjopen.bmj.com/content/12/1...

4 months ago 1 0 1 0

Surely, Hassabis and Amodei qualify as scientists. Need not be mutually exclusive

4 months ago 0 0 0 0

Surely the FIFA Prize would be awarded in Memory of Pele/Maradona/Beckenbauer

4 months ago 1 0 0 0

"Come for Epstein, stay for leniency designs" 😨

5 months ago 0 0 0 0

Directly go to the 3rd line of the email

5 months ago 4 0 0 0
Advertisement

A natural experiment beckons?!

6 months ago 0 0 0 0

Is this a Vinay in new form, or is it a recurrence?

8 months ago 1 0 0 0

Also, you can tell where they got inspiration for their ludicrous bar charts in demo

8 months ago 0 0 0 0

It looks to me that the model is fine-tuned/overfit on "how many r's in strawberry" type questions, hence the two r's to two b's

8 months ago 2 0 0 0

Holy hell, this is so good.
The comments highlighted some stuff I had overlooked and were very relevant too, unlike the generic ones one would get from ChatGPT/Claude. Surely, there is a human in the loop?

8 months ago 1 0 0 0

I would go one step further. I also had to come to terms with the fact that my slow work and fewer papers don't necessarily mean they are ground-breaking and better than someone's who is churning them out. I am just slow, period.

8 months ago 0 0 1 0

If you have "switch to a new todo app" in your todo list, then you would have completed at least one task

8 months ago 2 0 0 0

The transfer of one manuscript from one journal after rejection is increasingly becoming a clown show. It's not really a transfer if I have to reformat the manuscript, revise for new word count, and re-upload all documents.

8 months ago 0 0 0 0

Forgot to register for this event. Was it recorded, and if so, will the recording be posted anywhere?

8 months ago 0 0 1 0

Conduct and submit to a journal a descriptive study in an area where not much is known. Clearly mention the descriptive study design in title/objective.
Reviewer: This is a descriptive study and lacks rigor. What about [a bunch of confounders]?
Editor: Several methodological concerns. Reject.

8 months ago 0 0 0 0
Advertisement

Authors using AI to write papers.
Editors using AI to decide on sending papers for peer review.
Reviewers using AI to craft reviews.
Editors using AI to decide on acceptance/major revisions/minor revisions.
Readers using AI to summarize published articles.

9 months ago 2 0 0 0

In contrast, learning more about causal inference has made me more willing to apply for applied grants. Laying bare the assumptions (wrt confounding, bias, measurement) that need to hold for the estimates to be considered causal is how I approach it

9 months ago 2 0 0 0

I like to think multivariable modeling for descriptive questions (risk factors-type studies) as a form of standardization, if only a few important variables are considered, similar to reporting age-sex-standardized rates/values

9 months ago 1 0 1 0